• Novel 14-3-3 Interactors ATG9A and PTOV1 in Cancer Mechanism

  2026-05-08

  This study identifies ATG9A and PTOV1 as novel 14-3-3 binding proteins, elucidating their distinct roles in basal autophagy and oncogenic signaling. These mechanistic insights expand the understanding of 14-3-3-mediated regulation in tumorigenesis and highlight new targets for cancer research.

• Applied Workflows with DiscoveryProbe Bioactive Compound Lib

  2026-05-07

  Leverage the DiscoveryProbe™ Bioactive Compound Library Plus to streamline high-throughput screening, target validation, and pathway analysis in cancer, immunology, and signal transduction research. This guide details experimental protocol enhancements, advanced troubleshooting, and evidence-based optimization strategies for maximal assay reliability.

• Vorinostat (SAHA, MK0683): Reliable HDAC Inhibition for Onco

  2026-05-07

  This scenario-driven guide distills best practices for using Vorinostat (SAHA, MK0683) (SKU A4084) in cell viability and apoptosis workflows. Drawing from peer-reviewed literature and validated protocols, it addresses real-world assay challenges, data interpretation pitfalls, and vendor selection, highlighting how APExBIO's Vorinostat (SAHA, MK0683) ensures reproducibility and clarity in cancer biology research.

• Translating Bile Acid Subtypes to Precision qPCR Workflows

  2026-05-06

  This thought-leadership article examines how the intersection of bile acid metabolism subtyping in colorectal cancer and next-generation cDNA synthesis chemistry, exemplified by HyperScript™ III RT SuperMix for qPCR (with gDNA wiper), is transforming the rigor and translational value of immune biomarker analysis. By integrating mechanistic insight, recent genomic findings, and critical protocol guidance, it equips translational researchers to bridge molecular discovery and clinical implementation with unprecedented fidelity.

• Genistein: Applied Workflows in Cytoskeleton-Dependent Cance

  2026-05-06

  Harnessing Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) as a selective protein tyrosine kinase inhibitor transforms cancer chemoprevention and mechanotransduction assays. This article presents data-driven protocols, advanced troubleshooting, and actionable insights for maximizing reliability in cytoskeleton-dependent signaling and apoptosis studies.

• Adipose-Neural Axis Drives Arrhythmia via Leptin-NPY Signali

  2026-05-05

  Fan et al. (2024) establish a coculture model revealing how epicardial adipose tissue, through leptin-mediated neural activation, promotes cardiac arrhythmias. This work delineates the adipose-neural axis, identifies intervention targets such as leptin, NPY/Y1R, NCX, and CaMKII, and suggests new directions for mechanistic and therapeutic research.

• Hot-Melt Extrusion Enhances Ziprasidone HCl Bioavailability

  2026-05-05

  The referenced study demonstrates that combining Plasdone-S630 and HPMCAS-HF polymers via hot-melt extrusion dramatically improves the oral bioavailability of ziprasidone hydrochloride and eliminates the food effect. This innovation provides a robust formulation strategy for maximizing therapeutic consistency in both preclinical and clinical settings.

• Rotavirus-Induced Downregulation of Nrf2 Redox Response Path

  2026-05-04

  The referenced study demonstrates that progressive rotavirus infection disrupts cellular redox homeostasis by inducing a sharp decline in Nrf2 and its downstream antioxidant genes. This mechanistic insight advances our understanding of viral modulation of host stress responses, with implications for antiviral and oxidative stress research.

• Protease Inhibitor Cocktail: EDTA-Free Strategies for Protei

  2026-05-04

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) by APExBIO delivers broad-spectrum protection for proteins during cell and tissue extraction, ensuring high integrity for downstream assays. Learn practical workflow enhancements and expert troubleshooting tips derived from pioneering OXPHOS-targeting research.

• Ouabain in Translational Research: Mechanisms, Models, and S

  2026-05-03

  This thought-leadership article explores how Ouabain, a selective Na⁺/K⁺-ATPase inhibitor, is reshaping translational cardiovascular research. Through mechanistic insights, experimental strategies, and a competitive landscape review, we provide guidance for leveraging Ouabain in precision assays and animal models. The discussion bridges foundational ion transport biology to the future of personalized cardiovascular medicine, with evidence-labeled recommendations and protocol parameters for translational researchers.

• URB597 (KDS-4103): Deep Mechanistic Insights for Endocannabi

  2026-05-02

  Explore how URB597 (KDS-4103) enables precise, selective FAAH inhibition to dissect endocannabinoid signaling in vivo. This article delivers advanced mechanistic analysis, practical assay guidance, and unique translational perspectives for neuroplasticity and neuroinflammation research.

• SB743921 (SKU B1590): Precision KSP Inhibition in Cancer Res

  2026-05-02

  SB743921 (SKU B1590) is a potent, selective kinesin spindle protein inhibitor enabling reproducible cell cycle arrest and apoptosis studies in cancer research workflows. This article addresses real-world laboratory challenges, offering scenario-driven guidance and protocol insights for scientists seeking reliable, data-backed results with SB743921.

• MLKL Polymerization Drives Lysosomal Permeabilization in Nec

  2026-05-01

  This study reveals that MLKL polymerization at lysosomal membranes is a critical trigger for lysosomal membrane permeabilization (LMP) and subsequent necroptosis. The findings clarify the mechanistic link between MLKL activity and cathepsin-mediated cell death, offering new avenues for dissecting regulated necrosis in disease models.

• Palonosetron Hydrochloride in Preventing CINV: Mechanisms an

  2026-04-30

  This article reviews the innovation and clinical implications of palonosetron hydrochloride as a 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting (CINV) prevention. It highlights the pharmacologic distinctions, clinical trial findings, and comparative efficacy with other antiemetics, providing context for research involving cytotoxic agents such as Irinotecan (CPT-11).

• Xenobiotic Transporter Responses in Aedes aegypti to Dye Exp

  2026-04-30

  Kennel and Rouhier (2025) investigated how Aedes aegypti mosquitoes excrete synthetic dyes and how this process relates to the expression of putative organic cation transporters (OCT/Ns). Their findings reveal that the chemical structure of xenobiotics, rather than major shifts in transporter gene expression, primarily governs excretion patterns and mortality—informing future mosquito control strategies.

453 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page